Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals

Affiliations

¹ Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy. Electronic address: delia.goletti@inmi.it.
² Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
³ Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; The BRIGHT lab, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Institute, Salvador, Brazil.
⁴ Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
⁵ International Society for Infectious Diseases; S.H Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.

Free article

Editorial

Delia Goletti et al. Int J Infect Dis. 2025 Jan.

Free article

. 2025 Jan:150:107325.

doi: 10.1016/j.ijid.2024.107325. Epub 2024 Dec 2.

¹ Translational Research Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani"- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy. Electronic address: delia.goletti@inmi.it.
² Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Department of Medicine and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
³ Laboratory of Clinical and Translational Research, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; The BRIGHT lab, Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Institute, Salvador, Brazil.
⁴ Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
⁵ International Society for Infectious Diseases; S.H Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.

No abstract available

Keywords: Diabetes; Innovation; Investments; TB-HIV coinfection; Tuberculosis; WHO tuberculosis report.

Conflict of interest statement

Declarations of competing interest All authors declare no conflicts of interest.